SEARCH

SEARCH BY CITATION

References

  • 1
    Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378383.
  • 2
    Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3: 665673.
  • 3
    Zollinger HU, Moppert J, Thiel G, Rohr HP. Morphology and pathogenesis of glomerulopathy in cadaver kidney allografts treated with antilymphocyte globulin. Curr Top Pathol 1973; 57: 148.
  • 4
    Hamburger J, Crosnier J, Dormont J. Observations in patients with a well-tolerated homotransplanted kidney: Possibility of a new secondary disease. Ann N Y Acad Sci 1964; 120: 558577.
  • 5
    Starzl TE, Marchior TL, Faris TD et al. Problems and prognosis of chronically surviving patient after renal homotransplantation. Ann NY Acad Sci 1966; 129: 598614.
  • 6
    Hamburger J, Crosnier J, Dormont J. Experience with 45 renal homotransplantations in man. Lancet 1965; 17: 985992.
  • 7
    Porter KA, Dossetor JB, Marchioro TL et al. Human renal transplants: I. Glomerular changes Lab Invest 1967; 16: 153181.
  • 8
    Peterson EW, Mcphaul JJ, Mcintosh DA. Serial histologic alterations in human renal homotransplants. Am J Clin Pathol 1966; 45: 521532.
  • 9
    Hume DM, Lee HM, Williams GM et al. Comparative results of cadaver and related donor renal homografts in man and immunologic implications of outcome of second and paired transplants. Ann Surg 1966; 164: 352397.
  • 10
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.
  • 11
    Maryniak RK, First MR, Weiss MA. Transplant glomerulopathy: Evolution of morphologically distinct changes. Kidney Int 1985; 27: 799806.
  • 12
    Andresdottir MB, Assmann KJM, Koene RAP, Wetzels JFM. Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy. Am J Kidney Dis 1998; 32: 582588.
  • 13
    Porter KA, Andres GA, Calder MW et al. Human Renal Transplants .2. Immunofluorescent and immunoferritin studies. Lab Invest 1968; 18: 159171.
  • 14
    Hsu HC, Suzuki Y, Churg J, Grishman E. Ultrastructure of transplant glomerulopathy. Histopathology 1980; 6: 351367.
  • 15
    Mihatsch MJ, Nickeleit V, Gudat F. Morphologic criteria of chronic renal allograft rejection. Transplant Proc 1999; 31: 12951297.
  • 16
    Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574582.
  • 17
    Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 23712380.
  • 18
    Mroz A, Durlik M, Cieciura T, Lao M. Complement split product C4 as the indicator of immunological activity in chronic allograft rejection. Pol Merkur Lekarski 2003; 15: 363365.
  • 19
    Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004; 4: 124129.
  • 20
    Sijpkens YW, Joosten SA, Wong MC et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004; 65: 24092418.
  • 21
    Hood B, Olander R, Nagy Z, Bergentz SE. Glomerulopathy in the transplanted kidney. Scand J Urol/Nephrol 1970; 4: 135142.
  • 22
    Palomar R, Lopez-Hoyos M, Pastor JM et al. Impact of HLA antibodies on transplant glomerulopathy. Transplant Proc 2005; 37: 38303832.
  • 23
    Monga G, Mazzucco G, Novara R, Reale L. Intertubular capillary changes in kidney allografts: An ultrastructural study in patients with transplant glomerulopathy. Ultrastruct Pathol 1990; 14: 201209.
  • 24
    Monga G, Mazzucco G, Messina M, Motta M, Wuaranta S, Novara R. Intertubular capillary changes in kidney allografts: A morphologic investigation on 61 renal specimens. Mod Pathol 1992; 5: 125130.
  • 25
    Ivanyi B, Fahmy H, Brown H, Szenohradszky P, Halloran PF, Solez K. Peritubular capillaries in chronic renal allograft rejection: A quantitative ultrastructural study. Human Pathol 2000; 31: 11291138.
  • 26
    Mauiyyedi S, Nelson C, Tolkoff-Rubin N, Cosimi AB, Schneeberger EE, Colvin RB. Peritubular capillary lamination. A marker of antibody mediated chronic rejection of renal allografts. Mod Pathol 2000; 13:176A.
  • 27
    Ivanyi B, Kemeny E, Szederkenyi E, Marofka F, Szenohradszky P. The value of electron microscopy in the diagnosis of chronic renal allograft rejection. Mod Pathol 2001; 14: 12001208.
  • 28
    Gough J, Yilmaz A, Miskulin D et al. Peritubular capillary basement membrane reduplication in allografts and native kidney disease: A clinicopathologic study of 278 consecutive renal specimens. Transplantation 2001; 71: 13901393.
  • 29
    Solez K, Colvin RB, Racusen LC et al. Banff ‘05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (“CAN”). Am J Transplant 2007; 7: 518526.
  • 30
    Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708714.
  • 31
    Suri DL, Tomlanovich SJ, Olson JL, Meyer TW. Transplant glomerulopathy as a cause of late graft loss. Am J Kidney Dis 2000; 35: 674680.
  • 32
    Habib R, Broyer M. Clinical significance of allograft glomerulopathy. Kidney Int Suppl 1993; 43: S95S98.
  • 33
    Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 22082214.
  • 34
    Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 23262333.
  • 35
    Al Aly Z, Yalamanchili P, Cortese C, Salinas-Madrigal L, Bastani B. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: An uncommon finding. Transpl Int 2005; 18: 800805.
  • 36
    Drachenberg CB, Steinberger E, Hoehn-Saric E et al. Specificity of intertubular capillary changes: Comparative ultrastructural studies in renal allografts and native kidneys. Ultrastruct Pathol 1997; 21: 227233.
  • 37
    Smith RN, Kawai T, Boskovic S et al. Chronic antibody mediated rejection of renal allografts: Pathological, serological and immunologic features in nonhuman primates. Am J Transplant 2006; 6: 17901798.
  • 38
    Gloor JM, Cosio FG, Rea DJ et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006; 6: 18411847.
  • 39
    Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365: 15701576.
  • 40
    Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242251.
  • 41
    Akalin E, Dikman S, Murphy B, Bromberg JS, Hancock WW. Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am J Transplant 2003; 3: 11161120.